| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.11B | 60.56B | 59.15B | 58.58B | 54.40B | 52.43B |
| Gross Profit | 33.07B | 33.06B | 31.89B | 31.19B | 29.00B | 27.04B |
| EBITDA | 9.77B | 10.00B | 10.39B | 10.28B | 9.49B | 8.53B |
| Net Income | 2.77B | 2.95B | 3.13B | 2.70B | 2.56B | 2.29B |
Balance Sheet | ||||||
| Total Assets | 67.98B | 70.89B | 68.58B | 64.68B | 64.30B | 62.22B |
| Cash, Cash Equivalents and Short-Term Investments | 15.20B | 17.22B | 16.70B | 12.86B | 11.28B | 12.80B |
| Total Debt | 12.84B | 17.21B | 18.32B | 14.34B | 15.39B | 12.47B |
| Total Liabilities | 29.32B | 30.28B | 30.36B | 26.55B | 26.76B | 24.80B |
| Stockholders Equity | 38.67B | 40.61B | 38.21B | 38.12B | 37.54B | 37.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.71B | 3.06B | 4.13B | -568.00M | 3.67B |
| Operating Cash Flow | 0.00 | 7.45B | 7.83B | 8.93B | 6.01B | 10.41B |
| Investing Cash Flow | 0.00 | -4.93B | -5.62B | -6.69B | -7.78B | -7.00B |
| Financing Cash Flow | 0.00 | -2.50B | 633.00M | -2.66B | 316.00M | -1.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥33.17B | 13.14 | ― | 3.56% | 3.03% | 160.39% | |
76 Outperform | ¥9.73B | 6.60 | ― | 1.66% | 8.56% | 2690.35% | |
75 Outperform | ¥46.55B | 17.24 | ― | 2.97% | 0.89% | -14.25% | |
69 Neutral | ¥3.58B | 7.90 | ― | 4.00% | 11.73% | 37.16% | |
66 Neutral | ¥9.50B | 3.97 | ― | 2.65% | 1.11% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
46 Neutral | ¥10.92B | 34.54 | ― | 4.41% | 2.78% | -88.37% |
France Bed Holdings Co., Ltd. reported its consolidated financial results for the six months ended September 30, 2025, showing stable net sales but a decline in profits compared to the previous year. The company maintained its dividend forecast, indicating confidence in its financial stability despite the challenges. The results reflect a slight decrease in total assets and net assets, but an improvement in the equity-to-asset ratio, suggesting a more efficient use of resources. The company’s earnings forecast for the fiscal year ending March 31, 2026, anticipates modest growth in sales and profits, signaling a cautious but optimistic outlook.
The most recent analyst rating on (JP:7840) stock is a Buy with a Yen1451.00 price target. To see the full list of analyst forecasts on France Bed Holdings Co., Ltd. stock, see the JP:7840 Stock Forecast page.
France Bed Holdings Co., Ltd. announced an adjustment to the conversion price of its Zero Coupon Convertible Bonds due 2029, reducing it from 1,334.8 yen to 1,317.1 yen. This adjustment follows the approval of an interim dividend of 17 yen per share, reflecting the company’s adherence to the terms of the bonds and potentially impacting investor returns.
The most recent analyst rating on (JP:7840) stock is a Buy with a Yen1451.00 price target. To see the full list of analyst forecasts on France Bed Holdings Co., Ltd. stock, see the JP:7840 Stock Forecast page.
France Bed Holdings Co., Ltd. reported its consolidated financial results for the six months ended September 30, 2025, showing stable net sales but a decline in profits compared to the previous year. The company maintained its dividend forecast, reflecting confidence in its future performance despite the current challenges.
The most recent analyst rating on (JP:7840) stock is a Buy with a Yen1451.00 price target. To see the full list of analyst forecasts on France Bed Holdings Co., Ltd. stock, see the JP:7840 Stock Forecast page.